FDA approves most expensive drug ever, a gene therapy for hemophilia B
The single-dose medicine "represents important progress" as the first-ever gene therapy for the rare disorder, the FDA said.
Admin
Nov 23, 2022 - 14:00
The single-dose medicine "represents important progress" as the first-ever gene therapy for the rare disorder, the FDA said.